Physician profile
Mitul Dave
NPI 1396833604
$3,791.54
in general payments reported to CMS, 2019-2025
38 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $232 · 2021: $362 · 2022: $815 · 2023: $738 · 2024: $627 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653 · Education: $29.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,653.42 |
| Education | $29.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $877.05 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $341.92 | 2023-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Janssen Pharmaceuticals, INC | $222.08 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $214.72 | 2023-2024 | Aptiom, Gemtesa |
| Otsuka America Pharmaceutical, INC. | $196.68 | 2023-2025 | Rexulti, Abilify Maintena |
| Novartis Pharmaceuticals Corporation | $178.61 | 2019-2024 | |
| Xeris Pharmaceuticals, INC. | $171.61 | 2022-2023 | Gvoke Hypopen |
| Eisai INC. | $167.13 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $165.98 | 2019-2024 | Nuplazid |
| Urovant Sciences INC | $159.43 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $127.15 | 2024 | |
| Lundbeck LLC | $110.35 | 2023-2025 | Rexulti |
| Lilly USA, LLC | $98.08 | 2021-2025 | Mounjaro, Zepbound, Amyvid |
| Nestle Healthcare Nutrition INC. | $87.94 | 2022-2023 | |
| Neurelis, INC. | $83.71 | 2023 | Valtoco |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitul Dave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.